Global Influenza Drugs and Vaccines Market By Drugs (Zanamivir,

Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent,

Quadrivalent): Analysis By Region, By Country: Opportunities and
Forecast (2016-2021)
By Product Type- Vaccines,
Therapeutics
By Therapeutics - Relenza
(Zanamivir), Tamiflu (Oseltamivir
Phosphate), Rapivab (Peramivir)
By Region-North America, Europe,
APAC, ROW
By Country US, Canada, UK, France,
India, China
Policy & Regulations
Pipeline Analysis

May1
 Global Influenza Drugs and Vaccines Market By Drugs (Zanamivir, Oseltamivir
Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent): Analysis By Region, By
Country (2016-2021)
Global Coverage
Scope of the Study Segment Coverage
Regional Coverage By Drugs - Zanamivir, Oseltamivir Phosphate,
Drugs Type
Country Coverage Peramivir
Vaccines Type
By Vaccines Trivalent, Quadrivalent

Global Coverage Regional Coverage Country Coverage Company Coverage

Teva Pharmaceutical
North America Industries Ltd.
Europe U.S. Emergent Biosolutions
Asia Pacific Canada Sanofi Pasteur, Inc.
Influenza Market (2011-15)
ROW U.K. GlaxoSmithKline
Influenza Market (2016-21)
France Merck & Co., Inc.
Breakdown-By Product India CSL Limited
Type China Astrazeneca
Pfizer
Therapeutics (2011-2015) Serum Institute Of India
Therapeutics (2016-2021) Pvt. Ltd.
Protein Sciences
Vaccines Market (2011-15)
Corporation
Vaccines Market (2016-21)

Breakdown-By
Therapeutics Type

Relenza (zanamivir)
Tamiflu (oseltamivir
Influenza Market(2011-15) Product Benchmarking
Influenza Market (2016-21) Anti-Infective Vaccines Policy and Regulatory
phosphate)
Influenza Market : By Product Market (2011-15) Landscape
Rapivab (peramivir)
Type (2011-15) Anti-Infective Vaccines Financial Analysis
Influenza Market : By Product Market (2016-21) Sales
Breakdown By Vaccine Type (2016-21)
Business Strategy
Type Market Entry Strategy
Trivalent Vaccine
Quadrivalent Vaccine

2
S.N Particulars Page No.
o
1. Introduction 14

1.1. Research Methodology 14

1.2. Executive Summary 15

1.3. Strategic Recommendation 16

1.3. Product Overview 17

2. Global Influenza Market Overview 21

2.1. Global Influenza Market Size, By Value, Historic, 2011-2015 22

2.2. Global Influenza Market Size, By Value, Forecast, 2016-2021 23

3. Global Influenza Market, Product Analysis 24

3.1. By Product-Actual(2015) 25

3.2. By Product-Forecast(2021) 26

3.3. Global Influenza Therapeutics Market , Historic, 2011-2015 27

3.4. Global Influenza Therapeutics Market ,Forecast, 2016-2021 28

3.5. Global Influenza Vaccines Market, Historic, 2011-2015 29

3.6. Global Influenza Vaccines Market, Forecast, 2016-2021 30

(c) AZOTH Analytics 3

3.7. Global Influenza Therapeutics Market, By Drug Type 31
 S.No Particulars Page No.

4. Global Influenza Vaccines & Drugs - Pipeline Analysis 46

5. Global Influenza Market, By Region 48

5.1. By Region-Actual(2015) 49

5.2. By Region-Actual(2021) 50

6. North America Influenza Market Overview 51

6.1. North America Influenza Market Size, By Value, Historic, 2011-2015 52

6.2. North America Influenza Market Size, By Value, Forecast, 2016-2021 53

6.3. North America Influenza Therapeutics Market Size, By Value, Historic, 2011-2015 55

6.4. North America Influenza Therapeutics Market Size, By Value, Forecast , 2016-2021 56

6.5. North America Influenza Vaccines Market Size, By Value, Historic 2011-2015 58

6.6. North America Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 59

6.7. North America Influenza Therapeutics: Segment Analysis 60

6.8. North America Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015 61

6.9. North America Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021 62

6.10. North America Influenza Vaccines: Segment Analysis 63

6.11. North America Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015 64
(c) AZOTH Analytics 4
 S.No Particulars Page No.

7.9. Canada Influenza Therapeutics Market Size, By Value, Historic 2011-2015 75

7.10. Canada Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 75

7.11. Canada Influenza Vaccines Market Size, By Value, Historic 2011-2015 77

7.12. Canada Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 77

7.13. North America Other Influenza Market Size, By Value, Historic, 2011-2015 79

7.14. North America Other Influenza Market Size, By Value, Forecast, 2016-2021 79

8. Europe Influenza Market Overview 80

8.1. Europe Influenza Market Size, By Value, Historic, 2011-2015 81

8.2. Europe Influenza Market Size, By Value, Forecast, 2016-2021 82

8.3. Europe Influenza Therapeutics Market Size, By Value, Historic, 2011-2015 84

8.4. Europe Influenza Therapeutics Market Size, By Value, Forecast , 2016-2021 85

8.5. Europe Influenza Vaccines Market Size, By Value, Historic 2011-2015 87

8.6. Europe Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 88

8.7. Europe Influenza Therapeutics: Segment Analysis 89

(c) AZOTH Analytics 5

8.8. Europe Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015 90
S.No Particulars Page No.

10. France Influenza Market Overview 101

10.1. France Influenza Market Size, By Value, Historic, 2011-2015 102

10.2. France Influenza Market Size, By Value, Forecast, 2016-2021 102

10.3. France Influenza Therapeutics Market Size, By Value, Historic 2011-2015 104

10.4. France Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 104

10.5. France Influenza Vaccines Market Size, By Value, Historic 2011-2015 106

10.6. France Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 106

10.7. Europe Other Influenza Market Size, By Value, Historic, 2011-2015 108

10.8. Europe Other Influenza Market Size, By Value, Forecast, 2016-2021 108

11. APAC Influenza Market Overview 109

11.1. APAC Influenza Market Size, By Value, Historic, 2011-2015 110

11.2. APAC Influenza Market Size, By Value, Forecast, 2016-2021 111

11.3. APAC Influenza Therapeutics Market Size, By Value, Historic, 2011-2015 113

11.4. APAC Influenza Therapeutics Market Size, By Value, Forecast , 2016-2021 114

(c)2011-2015
AZOTH Analytics 6
11.5. APAC Influenza Vaccines Market Size, By Value, Historic 116
S.No Particulars Page
No.

12. India Influenza Market Overview

124

12.1. India Influenza Market Size, By Value, Historic, 2011-2015 125

12.2. India Influenza Market Size, By Value, Forecast, 2016-2021 125

12.3. India Influenza Therapeutics Market Size, By Value, Historic 2011-2015 127

12.4. India Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 127

12.5. India Influenza Vaccines Market Size, By Value, Historic 2011-2015 128

12.6. India Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 128

13. China Influenza Market Overview 129

13.1. China Influenza Market Size, By Value, Historic, 2011-2015 130

13.2. China Influenza Market Size, By Value, Forecast, 2016-2021 130

13.3. China Influenza Therapeutics Market Size, By Value, Historic 2011-2015 132

13.4. China Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 132

13.5. China Influenza Vaccines Market Size, By Value, Historic 2011-2015 134

13.6. China Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 134

(c) AZOTH Analytics 7

S.No Particulars Page
No.

14. ROW Influenza Market Overview 137

14.1. ROW Influenza Market Size, By Value, Historic, 2011-2015 138

14.2. ROW Influenza Market Size, By Value, Historic , 2016-2021 139

15. Market Dynamics 140

15.1. Drivers 140

15.2. Challenges 145

15.3. Trends 148

16. Company Profiles 153

16.1. GlaxoSmithKline 154

16.2. Sanofi Pasteur, Inc. 155

16.3. CSL Limited 156

16.4. Astrazeneca 157

16.5. Protein Sciences Corporation 158

16.6. Serum Institute Of India Pvt. Ltd. 159

16.7. Emergent Biosolutions 160

(c) AZOTH Analytics 8
List of Figures
Figure No. Figure Title Page No.
Figure 1: Global Influenza Market Size, By Value, 2011-2015 (USD Billion) 22

Figure 2: Global Influenza Market Size, By Value, 2016E-2021F (USD Billion) 23

Figure 3: Global Influenza Market Size and Share, By Product, 2015 25

Figure 4: Key Drivers 25
Figure 5: Global Influenza Market Size and Share, By Product, 2021F 26
Figure 6: Key Drivers 26
Figure 7: Global Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion) 27

Figure 8: Global Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion) 28

Figure 9: Global Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion) 29

Figure 10: Global Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion) 30

Figure 11: Global Zanamivir Market Size, By Value, 2011-2015 (USD Billion) 32

Figure 12: Global Zanamivir Market Size, By Value, 2016E-2021F (USD Billion) 33

Figure 13: Global Oseltamivir Phosphate Market Size, By Value, 2011-2015 (USD Billion) 35

Figure 14: Global Oseltamivir Phosphate Market Size, By Value, 2016E-2021F (USD Billion) 36

Figure 15: Global Peramivir Market Size, By Value, 2016E-2021F (USD Billion) 38

Figure 16: Global Trivalent Vaccines Market Size, By Value, 2011-2015 (USD Billion) 40

Figure 17: Global Trivalent Vaccines Market Size, By Value, 2016E-2021F (USD Billion) 41

Figure 18: Global Quadrivalent Vaccines Market Size, By Value, 2011-2015 (USD Billion) 43

Figure 19: Global Quadrivalent Vaccines Market Size, By Value, 2016E-2021F (USD Billion 44

9
List of Figures
Figure No. Figure Title Page
No.

Figure 20: Global Influenza Market Size and Share, By Region, 2015 49

Figure 21: Key Drivers 49

Figure 22: Global Influenza Market Size and Share, By Region, 2021F 50

Figure 23: Key Drivers 50

Figure 24: North America Influenza Market Size, By Value, 2011-2015 (USD Billion) 52

Figure 25: North America Influenza Market Size, By Value, 2016E-2021F (USD Billion) 53

Figure 26: North America Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion) 55

Figure 27: North America Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion) 56

Figure 28: North America Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion) 58

Figure 29: North America Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion) 59

Figure 30: North America Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion) 61

Figure 31: North America Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion) 62

Figure 32: North America Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion) 64

Figure 33: North America Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion) 65

Figure 34: US Influenza Market Size, By Value, 2011-2021(USD Billion) 67

Figure 35: US Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) 69

Figure 36: US Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) 71

10
List of Figures
Figure Figure Title Page
No. No.

Figure 37: Canada Influenza Market Size, By Value, 2011-2021(USD Billion) 73

Figure 38: Canada Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) 75

Figure 39: Canada Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) 77

Figure 40: North America Others Influenza Market Size, By Value, 2011-2021 (USD Billion) 79

Figure 41: Europe Influenza Market Size, By Value, 2011-2015 (USD Billion) 81

Figure 42: Europe Influenza Market Size, By Value, 2016E-2021F (USD Billion) 82

Figure 43: Europe Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion) 84

Figure 44: Europe Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion) 85

Figure 45: Europe Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion) 87

Figure 46: Europe Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion) 88

Figure 47: Europe Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion) 90

Figure 48: Europe Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion) 91

Figure 49: Europe Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion) 93

Figure 50: Europe Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion) 94

Figure 51: UK Influenza Market Size, By Value, 2011-2021(USD Billion) 96

Figure 52 : UK Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) 98

Figure UK Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) 100

53 :

11
List of Figures
Figure No. Figure Title Page
No.

Figure 54: France Influenza Market Size, By Value, 2011-2021(USD Billion) 102

Figure 55: France Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) 104

Figure 56: France Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) 106

Figure 57: Europe Others Influenza Market Size, By Value, 2011-2021 (USD Billion) 108

Figure 58: APAC Influenza Market Size, By Value, 2011-2015 (USD Billion) 110

Figure 59: APAC Influenza Market Size, By Value, 2016E-2021F (USD Billion) 111

Figure 60: APAC Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion 113

Figure 61: APAC Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion) 114

Figure 62: APAC Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion) 116

Figure 63: APAC Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion) 117

Figure 64: APAC Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion) 119

Figure 65: APAC Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion) 120

Figure 66: APAC Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion) 122

Figure 67: APAC Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion) 123

Figure 68: India Influenza Market Size, By Value, 2011-2021(USD Billion) 125

Figure 69: India Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) 127

Figure 70: India Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) 128

12
List of Figures
Figure No. Figure Title Page
No.

Figure 71: China Influenza Market Size, By Value, 2011-2021(USD Billion) 130

Figure 72: China Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) 132

Figure 73: China Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) 134

Figure 74: APAC Others Influenza Market Size, By Value, 2011-2021 (USD Billion) 136

Figure 75: ROW Influenza Market Size, By Value, 2011-2015 (USD Million) 138

Figure 76: ROW Influenza Market Size, By Value, 2016E-2021F (USD Million) 139

Table A: Influenza Pipe analysis 46

Table B: Influenza Pipe analysis 47

13
Global Influenza Market- Product Analysis
Rising number of cases around the globe along with rising awareness regarding the drug have been
propelling the market for influenza vaccination.

Figure : Global Influenza Market Size and Share, Figure : Key Drivers
By Product, 2015

15%

Vaccines

Therapeutic
s

85%

Source: Azoth Analytics

14
Global Influenza Vaccines Market
Rising affordability of the population along with increasing awareness among them and
development of a global vaccine is anticipated to drive the market in the forecast period.

Figure : Global Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)

CAGR: xxx%

2016E 2017F 2018F 2019F 2020F 2021F

Source: Azoth Analytics Estimates

xxxx

xxxxx

xxxxx

Xxxx
.

Xxxx

xxxx

15
North America Influenza Therapeutics Market

Figure 31: North America Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion)

2016E 2017F 2018F 2019F 2020F 2021F

Zanamivir Oseltamivir phosphate Peramivir

CAGR 2016E-2021F

Zanamivir: x% , Oseltamivir Phosphate: x%, Peramivir: x%

Source: Azoth Analytics Estimates

Xx

Xx

Xx

Xx

xx

16
France Influenza Market Overview
France Influenza Market is witnessing growth due to high penetration of vaccines and drugs in
this country as compared to other less developed countries.

Figure : France Influenza Market Size, By Value, 2011-2021(USD Billion)

CAGR: xxx% CAGR: xxx%

2011 2012 2013 2014 2015 2016E 2017F 2018F 2019F 2020F 2021F

Source: Azoth Analytics Estimates

xxxx

xxxxx

xxxx
.

xxxx

xxxxx

17
APAC Others Influenza Market Overview
The changed perception of the general population and continuous improvements in the
formulations of the vaccines and drugs is leading to the growth of this market.

Figure : APAC Others Influenza Market Size, By Value, 2011-2021 (USD Billion)

CAGR:xxx% CAGR: xxx%

0.334 0.364
0.275 0.304
0.217 0.246
0.159 0.174 0.188
0.130 0.144

2011 2012 2013 2014 2015 2016E 2017F 2018F 2019F 2020F 2021F
Source: Azoth Analytics Estimates

xxxx

xxxx

xxxx

xxxxx
.

xxxxx

xxxxx

18
Research Methodology

For our study on Global Influenza Drugs and Vaccines Market, we have conducted comprehensive
secondary research followed by an extensive primary research. In the process of secondary research,
we have scrutinized industry documents, accessed from open sources, premium paid databases
(Bloomberg, Thomson Reuters, Factiva) and our internal knowledge base. In the process of primary
research, we have interviewed various industry experts across the value chain of the Influenza Drugs
and Vaccines Market .

Market size of the actual period (2011-2016) has been evaluated on the basis of growth trends of
the industry in the last five years, and confirming the findings through primary research. Annual
reports of the companies are scanned to further validate the market size and to estimate the size of
various other end-user sectors. Market sizing and growth in the forecast period (2017-2022) is
estimated through product mapping, application in end-user industries, growth of allied sectors and
historical growth pattern of the industry. All the relevant data points/ statistics in the forecast period
are validated through relevant and reliable primary sources.

Report Focus: Global Influenza Drugs and Vaccines Market

-By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir),
-By Vaccine (Trivalent, Quadrivalent)
-By Region (North America, Europe, APAC, ROW),
-By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)
-Company Analysis - Falvogen, Gilead Science and Bio Cryst

19
Report Ordering

Global Influenza Drugs and Vaccines Market By Drugs (Zanamivir, Oseltamivir

Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By
Country: Opportunities and Forecast (2016-2021)-- By Region (North America, Europe,
APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)

Publish Date: May 2017

No. of Pages:164
Price: USD 2000 (Single User License)
Price: USD 3000 (Multi- User License)

To View Sample Report or Purchase Report Click Here

Contact
ASIA PACIFIC Us
EUROPE
Mail:info@azothanalytics.com
Mail:shipra@azothanalytics.com
NORTH AMERICA C
Phone:+91 120 429 8235
Assistance
Phone:+44 - 744 - 8107625
Mail:tanvi@azothanalytics.com Phone: +91
88
Phone:+1 - 321 - 444 9707 Sales Enq
www.azothanalytics Phone:
20